Thrombotic Events in COVID-19 Are Associated With a Lower Use of Prophylactic Anticoagulation Before Hospitalization and Followed by Decreases in Platelet Reactivity

Background: Coronavirus disease of 2019 (COVID-19) is associated with a prothrombotic state and a high incidence of thrombotic event(s) (TE).Objectives: To study platelet reactivity in hospitalized COVID-19 patients and determine a possible association with the clinical outcomes thrombosis and all-c...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Chantal C. Clark, Bernard N. Jukema, Arjan D. Barendrecht, Judith S. Spanjaard, Nikita K. N. Jorritsma, Simone Smits, Steven de Maat, Cor W. Seinen, Sandra Verhoef, Naomi M. J. Parr, Silvie A. E. Sebastian, Arnold C. Koekman, Annet C. W. van Wesel, Harriet M. R. van Goor, Roy Spijkerman, Suzanne H. Bongers, Erhard van der Vries, Stefan Nierkens, Marianne Boes, Leo Koenderman, Karin A. H. Kaasjager, Coen Maas
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Frontiers Media S.A. 2021-04-01
Rangatū:	Frontiers in Medicine
Ngā marau:	COVID-19 platelets SARS-CoV-2 thrombosis thrombotic event pulmonary thrombosis
Urunga tuihono:	https://www.frontiersin.org/articles/10.3389/fmed.2021.650129/full
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!